Gilead Sciences HIV PReP Gilead Sciences

Pay attention to seniors with HIV, advocates say

Reading now: 665
qvoicenews.com

Truvada, or PrEP, is a medication that can reduce HIV infection by more than 90 percent. Health officials consider it an important HIV prevention tool.

Democrats in the U.S. House of Representatives and the Senate have collaborated to reintroduce the PrEP Access and Coverage Act of 2023 to help reduce HIV.

One of the things that needs to be talked about is that many older people are living with HIV or are at risk of contracting the virus.

In 2021, the latest year for which data is available, people over age 50 accounted for 53 percent of people living with HIV in the U.S.

Read more on qvoicenews.com
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA